NASDAQ: BIAFBioaffinity Technologies Inc Stock Ownership - Who owns Bioaffinity Technologies?
Insider buying vs selling
Have Bioaffinity Technologies Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when BIAF insiders and whales buy or sell their stock.
BIAF Shareholders
What type of owners hold Bioaffinity Technologies Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gary D. Rubin | 320.44% | 1,730,741 | $16.32M | Insider |
| Steven Girgenti | 201.63% | 1,089,017 | $10.27M | Insider |
| Roby Joyce | 120.30% | 649,745 | $6.13M | Insider |
| Maria Zannes | 51.91% | 280,359 | $2.64M | Insider |
| Nathan M. Perlmutter | 30.75% | 166,089 | $1.57M | Insider |
| Robert A. Anderson | 30.35% | 163,936 | $1.55M | Insider |
| James Michael Edwards | 22.24% | 120,128 | $1.13M | Insider |
| Peter S. Knight | 21.75% | 117,455 | $1.11M | Insider |
| Mohsin Y. Meghji | 20.32% | 109,737 | $1.03M | Insider |
| Stuart Diamond | 18.35% | 99,088 | $934.40k | Insider |
BIAF vs Diagnostic & Research Stocks
Bioaffinity Technologies Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.